These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707 [TBL] [Abstract][Full Text] [Related]
9. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Jacquemart IC; Springs AE; Chen WY Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice. Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559 [TBL] [Abstract][Full Text] [Related]
11. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Henry MD; Triplett AA; Oh KB; Smith GH; Wagner KU Oncogene; 2004 Sep; 23(41):6980-5. PubMed ID: 15286714 [TBL] [Abstract][Full Text] [Related]
12. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Krane IM; Leder P Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899 [TBL] [Abstract][Full Text] [Related]
13. Involvement of Notch1 in the development of mouse mammary tumors. Diévart A; Beaulieu N; Jolicoeur P Oncogene; 1999 Oct; 18(44):5973-81. PubMed ID: 10557086 [TBL] [Abstract][Full Text] [Related]
14. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875 [TBL] [Abstract][Full Text] [Related]
16. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model. Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778 [TBL] [Abstract][Full Text] [Related]
17. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
18. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice. Jabrane-Ferrat N; Campbell MJ; Esserman LJ; Peterlin BM Cancer Gene Ther; 2006 Nov; 13(11):1002-10. PubMed ID: 16841083 [TBL] [Abstract][Full Text] [Related]
19. Induction of a variety of preneoplasias and tumours in the mammary glands of transgenic rats. Davies BR; Warren JR; Schmidt G; Rudland PS Biochem Soc Symp; 1998; 63():167-84. PubMed ID: 9513721 [TBL] [Abstract][Full Text] [Related]